Application no. and date | 09793471.5 (espacenet) (Federated) (European Patent Register), 20091214 | Patent/reg. no. and date | DK/EP 2379592, 20150211 | Publication date | 20111026 | Priority no. and date | EP 08021835, 20081216 | EP pub. no. and date |
EP 2379592 20111026 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | P55423DK01 | Inventor | BRINKMANN, Ulrich, Feichtlstrasse 12
82362 Weilheim, DE, SCHEUER, Werner, Primelstrasse 3
82377 Penzberg, DE, KAVLIE, Anita, Stromsborgveien 39H
0287 Oslo, NO, KLEIN, Christian, Chruezacherweg 41
8906 Bonstetten, CH, GRIEP, Remko Albert, Odalsveien 31 B
3470 Slemmestad, NO, KALUZA, Klaus, Tankenrain 3
82362 Weilheim, DE, REGULA, Joerg Thomas, Innerkoflerstr.17
81377 München, DE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/22 (2006.01) | Title | ANTISTOFFER MOD HUMANT ANGIOPOIETIN 2 | Int. application no. | EP2009008930 | Int. publication no. | WO2010069532 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|